Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
11/2000
11/09/2000WO2000066119A1 Novel prolines as antimicrobial agents
11/09/2000WO2000066102A2 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
11/09/2000CA2372948A1 Method of enhancing insulin action
11/09/2000CA2372176A1 Novel prolines as antimicrobial agents
11/09/2000CA2371391A1 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
11/08/2000EP1050525A1 Substances capable of inducing apoptosis
11/08/2000EP1049694A1 Benzothiadiazoles and derivatives
11/08/2000EP1049678A2 Cyclohexyl and heterocyclyl nucleoside derivatives, method for producing these derivatives, and the use of the derivatives and their oligomers or conjugates in pairing and/or testing systems
11/08/2000EP0727959A4 Diagnostic uses of hydrazinoadenosines
11/08/2000CN1058260C Na-2-(4-nitrophenulsulfonyl) ethoxycarbonyl-amino acid
11/07/2000US6143749 Heterocyclic substituted cyclopentane compounds
11/07/2000US6143743 Treatment of nervous system disorders
11/02/2000WO2000064484A2 Conjugate having a cleavable linkage for use in a liposome
11/02/2000WO2000039143A3 Antiviral nucleoside analogues
11/02/2000EP1047705A2 Nucleobase oligomers
10/2000
10/31/2000US6140351 Ortho-anthranilamide derivatives as anti-coagulants
10/26/2000WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
10/25/2000EP1045850A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
10/25/2000EP1045849A1 Purine derivatives having phosphodiesterase iv inhibition activity
10/24/2000US6137007 Enantiomer compositions of (1R,4S)-1-butyrylamino-4-(hydroxymethyl)-2-cyclopentene
10/24/2000US6136813 Viricides for hepatitis b
10/19/2000WO2000061583A1 Xanthine derivatives and analogs as cell signaling inhibitors
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000061537A2 Pharmaceutical compounds
10/19/2000CA2370425A1 Pharmaceutical compounds
10/19/2000CA2369981A1 Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same
10/18/2000EP1044969A2 Processes and intermediates for preparing anti-cancer compounds
10/18/2000EP1044201A1 3-substituted adenines via2-thioxanthines
10/18/2000EP0633886B1 Pharmaceutically active bicyclic-heterocyclic amines
10/18/2000CN1057443C Method for preparing antiviral medicinal compositions
10/17/2000US6133444 Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
10/17/2000US6133276 A ligand inhibitor of a crf/crf-binding protein complex to effect increased levels of crf; 2,4-dioxo- or 2-thiocarbonyl-4-oxo-5-(hydrocarbyl(thio)carbonylaminomethyl)-6-hydroxy-hexa-hexahydropyrimidines; alzheimer's, obesity; low side effects
10/17/2000US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
10/12/2000WO2000059906A1 Aminoheterocycle-substituted glycerols
10/12/2000WO2000059449A2 Purine derivatives having phosphodiesterase iv inhibition activity
10/12/2000CA2367143A1 Purine derivatives having phosphodiesterase iv inhibition activity
10/11/2000EP1043324A1 Purine derivatives and medicine containing the same as the active ingredient
10/11/2000EP1043021A1 Type 2 helper t cell-selective immune response suppressors
10/11/2000EP1042509A1 Methods of using oligonucleotide arrays to search for new kinase inhibitors
10/11/2000EP1042356A2 Intermediates and process for the synthesis of 17-unsubstituted 16.beta.-aryloxy 4-azasteroids
10/11/2000CN1269801A Purine acyclonucleosides as antiviral agents
10/11/2000CN1269800A Tetrahydro Gamma-carbolines
10/10/2000US6130221 Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions
10/10/2000CA2080231C 2'-o-alkylnucleotides as well as polymers which contain such nucleotides
10/05/2000WO2000058305A1 Novel compounds
10/05/2000CA2361366A1 Novel compounds
10/04/2000EP1041072A1 Dioxocyclopentyl hydroxamic acids
10/04/2000EP1040831A2 Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
10/04/2000EP1040108A1 Ortho-anthranilamide derivatives as anti-coagulants
10/04/2000EP0772439B1 Novel antibiotic compounds and antibiotic compositions comprising said compounds for inhibiting gram positive bacteria and mycoplasma cells.
10/03/2000US6127539 N-phosphorylation or sulfonylation of 2-azabicyclo(2.2.1) hept-5-en-3-one in the presence of an organolithium compound and at a subzero temperature, then reacting with a purine base to yield the cyclopentenyl nucleoside
09/2000
09/28/2000WO2000056738A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000CA2367866A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/27/2000CN1268137A Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
09/26/2000US6124330 N-[4-(Heteroarylmethyl)phenyl]-heteroarylamines
09/26/2000US6124321 An enzyme inhibitor for enhancing memory or treating or preventing alzheimer's disease
09/26/2000US6124304 Penciclovir for the treatment of zoster associated pain
09/26/2000US6124300 Treating anxiety or depression
09/26/2000US6124288 Phosphodiesterase iv inhibitors
09/21/2000WO2000055161A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents
09/21/2000CA2367354A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents
09/20/2000EP1036794A1 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
09/20/2000EP1036058A1 Adamantane derivatives
09/19/2000US6121431 Nucleoside derivatives
09/19/2000US6121418 PNA synthesis using a base-labile amino protecting group
09/19/2000US6121316 2-cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives
09/19/2000US6121270 N-(epoxyalkyl)xanthine derivatives which modulate cellular responses to noxious, pro-inflammatory stimuli
09/19/2000CA2018563C N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments
09/14/2000WO2000053604A1 Carbamoyl tetrahydropyridine derivatives
09/14/2000WO2000053603A1 2-hydroxy methylcyclopro pylidenemethyl purines and -pyrimidines as antiviral agents
09/14/2000CA2366642A1 Carbamoyl tetrahydropyridine derivatives
09/13/2000EP1035123A1 Novel heterocyclic compounds
09/13/2000EP0764166B1 Corticotropin releasing factor antagonists
09/13/2000EP0586570B1 Backbone modified oligonucleotide analogues
09/12/2000US6117998 A1 adenosine receptor antagonists
09/08/2000WO2000051993A2 Dihetero-substituted metalloprotease inhibitors
09/08/2000CA2366954A1 Dihetero-substituted metalloprotease inhibitors
09/06/2000EP1032573A1 Process for preparing a chiral nucleoside analogue
09/05/2000US6114525 Method for purifying nucleic acid derivatives
08/2000
08/31/2000WO2000050431A1 Platinum (ii) compounds
08/31/2000WO2000012074A3 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
08/31/2000CA2364712A1 Platinum (ii) compounds
08/30/2000EP1030666A1 Novel use of compounds for anti-pruritic activity
08/29/2000US6110923 Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity
08/29/2000US6110458 Cancer therapy utilizing ex vivo gene transduction
08/24/2000WO2000049018A1 2-amino-6-anilino-purines and their use as medicaments
08/24/2000CA2360353A1 2-amino-6-anilino-purines and their use as medicaments
08/23/2000EP1028682A1 Transdermal propentofylline compositions for the treatment of alzheimer's disease
08/23/2000CN1264387A Nucleotide analog composition and synthesis method thereof
08/23/2000CN1264377A Substituted pyrazoles as P38 kinase inhabitors
08/22/2000US6107302 Storage stable valaciclovir in anhydrous crystalline form; viricide against herpes virus
08/22/2000US6107301 1N-alkyl-N-arylpyrimidinamines and derivatives thereof
08/22/2000US6107300 Arylamino fused pyrimidines
08/22/2000US6107297 2,4-Dithi(oxo)-pyrimidin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists
08/22/2000US6107064 Producing adenosine a1 receptor antagonist by selecting enzyme source for catalyzing hydroxylation or carbonylation and mixing compound with enzyme
08/17/2000WO2000047581A1 Therapeutic nucleoside compound
08/17/2000WO2000012076A9 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
08/16/2000CN1263529A Carbocyclic nucleoside hemisulfate and its use in treating viral infectiosn
08/15/2000US6103901 Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
08/15/2000US6103737 Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 120